Free Trial

National Vision (EYE) Competitors

National Vision logo
$11.70 -0.67 (-5.42%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$11.70 +0.01 (+0.04%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EYE vs. NVST, PRCT, IRTC, WRBY, LIVN, ENOV, NVCR, TMDX, LMAT, and TNDM

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry.

National Vision vs.

Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking.

Envista presently has a consensus price target of $20.21, indicating a potential downside of 3.33%. National Vision has a consensus price target of $13.40, indicating a potential upside of 14.53%. Given National Vision's stronger consensus rating and higher possible upside, analysts plainly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
2 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.07
National Vision
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

National Vision received 220 more outperform votes than Envista when rated by MarketBeat users. Likewise, 65.30% of users gave National Vision an outperform vote while only 35.79% of users gave Envista an outperform vote.

CompanyUnderperformOutperform
EnvistaOutperform Votes
34
35.79%
Underperform Votes
61
64.21%
National VisionOutperform Votes
254
65.30%
Underperform Votes
135
34.70%

Envista has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500.

National Vision has a net margin of -0.81% compared to Envista's net margin of -44.56%. Envista's return on equity of 3.86% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista-44.56% 3.86% 2.21%
National Vision -0.81%3.52%1.39%

In the previous week, Envista and Envista both had 4 articles in the media. Envista's average media sentiment score of 1.11 beat National Vision's score of 1.06 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision has lower revenue, but higher earnings than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.51B1.43-$1.12B-$6.49-3.22
National Vision$2.13B0.43-$65.90M-$0.20-58.50

Summary

National Vision beats Envista on 8 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionOphthalmic goods IndustryStaples SectorNASDAQ Exchange
Market Cap$921.38M$11.14B$17.03B$8.95B
Dividend YieldN/A1.63%2.90%3.85%
P/E Ratio-58.5036.1116.3118.81
Price / Sales0.434.753.8376.66
Price / Cash7.0414.6716.7237.47
Price / Book1.103.046.914.64
Net Income-$65.90M$230.61M$734.56M$245.69M
7 Day Performance-5.87%-1.61%-0.34%-2.64%
1 Month Performance2.18%-8.13%0.21%-2.37%
1 Year Performance-41.76%-11.60%10.04%13.63%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.3726 of 5 stars
$11.70
-5.4%
$13.40
+14.5%
-41.8%$921.38M$2.13B-58.5013,998Positive News
NVST
Envista
3.544 of 5 stars
$21.59
+0.3%
$20.21
-6.4%
-6.5%$3.71B$2.51B-3.3312,800
PRCT
PROCEPT BioRobotics
3.2668 of 5 stars
$67.61
-2.4%
$97.86
+44.7%
+28.3%$3.53B$199.84M-34.67430Positive News
IRTC
iRhythm Technologies
1.1354 of 5 stars
$112.11
-0.1%
$108.45
-3.3%
+6.8%$3.51B$492.68M-23.072,000Earnings Report
Analyst Forecast
News Coverage
Gap Up
WRBY
Warby Parker
2.5425 of 5 stars
$25.70
-2.7%
$21.77
-15.3%
+71.6%$2.61B$669.77M-95.193,491Upcoming Earnings
Analyst Forecast
LIVN
LivaNova
3.5803 of 5 stars
$47.68
+0.1%
$69.17
+45.1%
-16.5%$2.59B$1.15B113.522,900Upcoming Earnings
ENOV
Enovis
3.4615 of 5 stars
$43.89
+0.4%
$64.83
+47.7%
-29.1%$2.50B$1.71B-20.046,550Short Interest ↓
Positive News
NVCR
NovoCure
3.4804 of 5 stars
$22.48
+3.5%
$32.67
+45.3%
+41.4%$2.43B$509.34M-16.061,453Upcoming Earnings
News Coverage
TMDX
TransMedics Group
3.6152 of 5 stars
$72.18
+1.3%
$122.70
+70.0%
-17.3%$2.42B$241.62M76.79210News Coverage
Gap Up
LMAT
LeMaitre Vascular
1.9524 of 5 stars
$98.65
+1.7%
$94.63
-4.1%
+59.9%$2.22B$193.48M53.91490
TNDM
Tandem Diabetes Care
4.0868 of 5 stars
$33.47
+2.6%
$53.81
+60.8%
+37.5%$2.20B$747.72M-17.342,400Positive News

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners